-       Report 
- September 2022
-  110 Pages 
- Global 
   From       €4919EUR$5,500USD£4,327GBP 
          -       Report 
- August 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- March 2024
-  133 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- March 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
          -       Report 
- July 2024
-  120 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
           -       Report 
- February 2024
-  115 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- April 2023
-  206 Pages 
- Global 
   From       €3131EUR$3,500USD£2,754GBP 
      €6261EUR$7,000USD£5,508GBP 
            -       Report 
- February 2022
-  199 Pages 
- Global 
   From       €2348EUR$2,625USD£2,065GBP 
      €4696EUR$5,250USD£4,131GBP 
            -       Report 
- March 2024
-  147 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- August 2023
-  114 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- October 2025
-  150 Pages 
- Germany 
   From       €3444EUR$3,850USD£3,029GBP 
            -       Report 
- September 2024
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- October 2023
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- February 2023
-  126 Pages 
- Europe 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- June 2025
-  250 Pages 
- India 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- June 2024
-  183 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- January 2024
-  119 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- July 2024
-  187 Pages 
- China 
   From       €1610EUR$1,800USD£1,416GBP 
          -       Report 
- July 2024
-  326 Pages 
- China 
   From       €3578EUR$4,000USD£3,147GBP 
          -       Report 
- March 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
       
      DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be    produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less   Read more